{
  "ptid_time": "023_S_1262_2007-02-28",
  "img_path": "/data/qiuhui/data/adni/images/023_S_1262/2007-02-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 35,424 mm³, 26.2% above the reference mean. With a Z-score of 0.60 (72.6th percentile), this represents normal volume ; hippocampal volume measures 5,054 mm³, 29.0% below the reference mean. With a Z-score of -2.66 (0.4th percentile), this represents significant atrophy; whole brain volume measures 855,952 mm³, 12.2% below the reference mean. With a Z-score of -1.53 (6.3th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,162 mm³, 41.1% below the reference mean. With a Z-score of -2.52 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 12,149 mm³, 28.6% below the reference mean. With a Z-score of -2.60 (0.5th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,073 mm³, 21.4% below the reference mean. With a Z-score of -1.86 (3.2th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 72.7 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Musculoskeletal; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 21.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 529.50 pg/mL (mild reduced); Total tau: 481.80 pg/mL (profound elevated); Phosphorylated tau: 50.13 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, entorhinal cortex, and fusiform gyrus—key regions affected in Alzheimer’s disease (AD). The CSF biomarkers (elevated T-tau and P-tau with mildly reduced Aβ) are consistent with AD pathology, and the MMSE score of 21 indicates cognitive impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T02:57:38.065375"
}